Crossing occlusions in blood vessels

Information

  • Patent Grant
  • 11065002
  • Patent Number
    11,065,002
  • Date Filed
    Wednesday, December 20, 2017
    6 years ago
  • Date Issued
    Tuesday, July 20, 2021
    3 years ago
Abstract
The present disclosure is directed a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method may include providing a first intravascular device having a distal portion and at least one aperture and positioning the distal portion of the first intravascular device in the vascular wall. The method may further include providing a reentry device having a body and a distal tip, the distal tip having a natural state and a compressed state and inserting the distal tip, in the compressed state, in the distal portion of the first intravascular device. The method may further include advancing the distal tip, in the natural state, through the at least one aperture of the first intravascular device.
Description
FIELD OF THE INVENTION

The inventions described herein relate to devices and associated methods for the treatment of chronic total occlusions. More particularly, the inventions described herein relate to devices and methods for crossing chronic total occlusions and establishing a pathway for blood flow past the chronic total occlusions.


BACKGROUND OF THE INVENTION

Due to age, high cholesterol and other contributing factors, a large percentage of the population has arterial atherosclerosis that totally occludes portions of the patient's vasculature and presents significant risks to patient health. For example, in the case of a total occlusion of a coronary artery, the result may be painful angina, loss of cardiac tissue or patient death. In another example, complete occlusion of the femoral and/or popliteal arteries in the leg may result in-limb threatening ischemia and limb amputation.


Commonly known endovascular devices and techniques are either inefficient (time consuming procedure), have a high risk of perforating a vessel (poor safety) or fail to cross the occlusion (poor efficacy). Physicians currently have difficulty visualizing the native vessel lumen, cannot accurately direct endovascular devices toward the visualized lumen, or fail to advance devices through the lesion. Bypass surgery is often the preferred treatment for patients with chronic total occlusions, but less invasive techniques would be preferred.


Described herein are devices and methods employed to exploit the vascular wall of a vascular lumen for the purpose of bypassing a total occlusion of an artery. Exploitation of a vascular wall may involve the passage of an endovascular device into and out of said wall which is commonly and interchangeable described as false lumen access, intramural access, submedial access or in the case of this disclosure, subintimal access.


SUMMARY OF THE INVENTION

Described herein are devices and methods employed to exploit the vascular wall of a vascular lumen for the purpose of bypassing a total occlusion of an artery. Exploitation of a vascular wall may involve the passage of an endovascular device into and out of said wall which is commonly and interchangeable described as false lumen access, intramural access, submedial access or in the case of this disclosure, subintimal access.


In one aspect, the present disclosure is directed a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method may include providing a first intravascular device having a distal portion and at least one aperture and positioning the distal portion of the first intravascular device in the vascular wall. The method may further include providing a reentry device having a body and a distal tip, the distal tip having a natural state and a compressed state and inserting the distal tip, in the compressed state, in the distal portion of the first intravascular device. The method may further include advancing the distal tip, in the natural state, through the at least one aperture of the first intravascular device.


In another aspect, the present disclosure is directed an apparatus for facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The apparatus may include a first intravascular device having a distal portion, the distal portion including at least one aperture, at least one radiopaque marker, and at least one orienting element. The apparatus may further include a reentry device having a body and a distal tip, the distal tip having a natural state and a compressed state.


Additional objects and advantages of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.


It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.


The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate several embodiments of the invention and together with the description, serve to explain the principles of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a cross-sectional view of an artery with a wall having three layers. The outermost layer of the wall is the adventitia and the innermost layer is the intima. The tissues extending between the intima and the adventitia may be collectively referred to as the media.



FIG. 2 is an additional view of the artery shown in the previous figure in which a crossing device has been advanced over guidewire so that a distal portion of the crossing device is disposed in a proximal segment of a true lumen of the artery.



FIG. 3 is an additional view of the artery shown in the previous figure in which the distal end of the crossing device has been advanced in a distal direction so that a tip of the crossing device is adjacent to an occlusion.



FIG. 4 is an additional view of the artery and crossing device shown in the previous figure. In the embodiment of FIG. 4, the distal end of the crossing device has been advanced in an axial direction past the occlusion.



FIG. 5 is a view of the artery shown in the previous figure showing that the crossing device has been withdrawn from the true lumen of the artery.



FIG. 6 is an additional view of the artery and the guidewire shown in the previous figure. In the embodiment of FIG. 6, an orienting device has been advanced over the guidewire.



FIG. 7 is an additional view of the artery and the orienting device shown in the previous figure. In the embodiment of FIG. 7, the guidewire has been withdrawn leaving the orienting device in the position shown in FIG. 7.



FIG. 8 is an additional view of the artery and the orienting device shown in the previous figure. In the embodiment of FIG. 8, a re-entry device has been advanced into the lumen of the orienting device.



FIG. 9 is an enlarged partial cross-sectional view showing a portion of the re-entry device and the orienting device shown in the previous figure.



FIG. 10 is an additional partial cross-sectional view showing a portion of the re-entry device and the orienting device shown in the previous figure.



FIG. 11 is an enlarged partial cross-sectional view showing a portion of the re-entry device and the orienting device shown in the previous figure.



FIG. 12 is another enlarged partial cross-sectional view showing a portion of the re-entry device shown in the previous figure. In the embodiment of FIG. 12, a core of the re-entry device has been advanced so that a portion of the core extends beyond the body of the re-entry device.



FIG. 13 is an additional enlarged partial cross-sectional view showing a portion of the re-entry device shown in the previous figure. In the embodiment of FIG. 13, the re-entry device has been advanced so that a penetrator is contacting the intima of an artery.



FIG. 14 is yet another enlarged partial cross-sectional view showing a portion of the re-entry device shown in the previous figure. In the embodiment of FIG. 14, the penetrator of the re-entry device has pierced the intima.



FIG. 15 is still another enlarged partial cross-sectional view showing a portion of the re-entry device shown in the previous figure. In the embodiment of FIG. 15, the re-entry device has been advanced so that the distal end of the re-entry device is disposed in the true lumen of an artery.



FIG. 16 is a partial cross-sectional view of the re-entry device shown in the previous figure. FIG. 16 has a different scale than the previous figure so that more of the surrounding context is visible in FIG. 16.



FIG. 17 is an additional view of the artery shown in the previous figure. In the embodiment of FIG. 17, an orienting device has been withdrawn leaving a reentry device in the position shown in FIG. 17.



FIG. 18 is a plan view of a crossing device in accordance with the present description. In the embodiment of FIG. 19, a penetrator of the crossing device is assuming a deployed position.



FIG. 19 is an additional plan view of the re-entry device shown in the previous figure. In the embodiment of FIG. 19, a penetrator of the crossing device is assuming a retracted position.



FIG. 20 is a plan view of an exemplary re-entry device. Selected dimensions of the exemplary re-entry device are illustrated in FIG. 20.



FIG. 21 and FIG. 22 illustrate a method in which a re-entry device has been advanced while a core is in a retracted position. These figures show that the reentry device has not penetrated intima. Instead, the re-entry device has been advanced between the intima and the exterior of the orienting device.



FIG. 23A is a cross-sectional view of an orienting device including a radiopaque marker.



FIG. 23B is a representation of a fluoroscopic display. The radiopaque marker of the orienting device shown in the previous figure is visible in this fluoroscopic display. A radiopaque re-entry device is also visible in this display.



FIG. 24 is a plan view including the orienting device shown in the previous figure. In FIG. 24, a distal portion of a re-entry device can be seen extending through an aperture of the orienting device.



FIG. 25A is a cross-sectional view of an orienting device including a radiopaque marker.



FIG. 25B is a representation of a fluoroscopic display. The radiopaque marker of the orienting device shown in the previous figure is visible in this fluoroscopic display. A radiopaque re-entry device is also visible in this display.



FIG. 26 is a plan view including the orienting device shown in the previous figure. A first balloon and a second balloon of the orienting device are visible in FIG. 26.



FIG. 27 is a cross sectional view of the orienting device shown in the previous figure. A cut of the cross-sectional view is taken along line A-A shown in FIG. 27.



FIG. 28 is a cross-sectional view of an artery with a wall having three layers. The outermost layer of the wall is the adventitia and the innermost layer is the intima. In FIG. 28, an orienting device is shown disposed between the adventitia and the intima.



FIG. 29 is a partial cross-sectional view of an exemplary crossing device comprising a tip that is fixed to a distal end of a shaft.



FIG. 30 is a plan view showing an assembly including the crossing device shown in the previous figure. In the embodiment of FIG. 30, a drive assembly is coupled to the shaft of the crossing device.



FIG. 31 is a cross-sectional view of the assembly shown in the previous figure. The assembly includes a drive assembly comprising a central gear, an internal gear and a plurality of planetary gears. These gears form a gear train that provides a mechanical advantage.





DESCRIPTION OF THE EMBODIMENTS

Reference will now be made in detail to the present embodiments of the invention, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.


The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.



FIG. 1 is a cross-sectional view of an artery 20 having a wall 22. In FIG. 1, wall 22 of artery 20 is shown having three layers. The outermost layer of wall 22 is the adventitia 24 and the innermost layer of wall 22 is the intima 26. The tissues extending between intima 26 and adventitia 24 may be collectively referred to as the media 28. For purposes of illustration, intima 26, media 28 and adventitia 24 are each shown as a single homogenous layer in FIG. 1. In the human body, however, the intima and the media each comprise a number of sub-layers. The transition between the external most portion of the intima and the internal most portion of the media is sometimes referred to as the subintimal space. Intima 26 defines a true lumen 30 of artery 20. In FIG. 1, an occlusion 36 is shown blocking true lumen 30. Occlusion 36 divides true lumen 30 into a proximal segment 32 and a distal segment 34. In FIG. 1, a distal portion of a guidewire 102 is shown extending into proximal segment 32 of true lumen 30.


As shown in FIG. 1, methods described in this document may include the step of advancing a guidewire to a location proximate an occlusion in a blood vessel. The exemplary methods described in this document may also include the step of advancing guidewire 102 between occlusion 36 and adventitia 24. In some cases, however, the nature of the occlusion and the blood vessel will be such that the guidewire is unlikely to advance beyond the occlusion.



FIG. 2 is an additional view of artery 20 shown in the previous figure. In the embodiment of FIG. 2, a crossing device 104 has been advanced over guidewire 102 so that a distal portion of crossing device 104 is disposed in proximal segment 32 of true lumen 30. Crossing device 104 may be used to establish a channel between proximal segment 32 and distal segment 34. Crossing device 104 of FIG. 2 comprises a tip 108 that is fixed to a distal end of a shaft 120. As shown in FIG. 2, methods described in this document may include the step of advancing a crossing device over a guidewire.



FIG. 3 is an additional view of artery 20 shown in the previous figure. In the embodiment of FIG. 3, the distal end of crossing device 104 has been advanced in a distal direction so that tip 108 is adjacent to occlusion 36. With reference to FIG. 3, it will be appreciated that tip 108 has passed through intima 26 and is disposed between occlusion 36 and adventitia 24 of artery 20. Some methods described in this document may include the step of advancing a crossing device between an occlusion and the adventitia of an artery.



FIG. 4 is an additional view of artery 20 and crossing device 104 shown in the previous figure. In the embodiment of FIG. 4, the distal end of crossing device 104 has been advanced in an axial direction past occlusion 36. Accordingly, it will be appreciated that methods described in this document may include the step of advancing a crossing device beyond an occlusion.


In the embodiment of FIG. 4, crossing device has crossed occlusion 36 by advancing between occlusion 36 and adventitia 24 of artery 20. It is to be appreciated that other methods of crossing an occlusion are within the spirit and scope of this disclosure. For example, the crossing device 104 may pass through occlusion 36 while remaining disposed inside true lumen 30.


In FIG. 4, tip 108 of crossing device 104 is shown residing between intima 26 and adventitia 24 of artery 20. As tip 108 moves in an axial direction between intima 26 and adventitia 24, tip 108 may cause blunt dissection of the layers forming the wall of artery 20. Alternatively, tip 108 may cause blunt dissection of the materials comprising the occlusion 36.


In some useful methods in accordance with the present disclosure, crossing device 104 is rotated about its longitudinal axis and moved in a direction parallel to its longitudinal axis simultaneously. When this is the case, rotation of crossing device 104 may reduce resistance to the axial advancement of crossing device 104. These methods take advantage of the fact that the kinetic coefficient of friction is usually less than the static coefficient of friction for a given frictional interface. Rotating crossing device 104 assures that the coefficient of friction at the interface between the crossing device and the surround tissue will be a kinetic coefficient of friction and not a static coefficient of friction.


With reference to FIG. 4, it will be appreciated that crossing device 104 extends past occlusion 36. In FIG. 4, occlusion 36 is shown blocking a true lumen 30. Occlusion 36 divides true lumen 30 into a proximal segment 32 and a distal segment 34. When a crossing device in accordance with some embodiments of the present disclosure is advanced through the subintimal space of an artery, the distal end of the crossing device may penetrate the intima and enter the distal segment of the true lumen after advancing beyond an occlusion. When this is the case, fluid communication between the proximal segment and the distal segment may be achieved via a channel created by the crossing device.



FIG. 5 is an additional view of artery 20 shown in the previous figure. In the embodiment of FIG. 5, crossing device 104 has been withdrawn from true lumen 30 of artery 20. With reference to FIG. 5, it will be appreciated that guidewire 102 remains in the position formerly occupied by crossing device 104.


The position of guidewire 102 shown in FIG. 5 may be achieved using crossing device 104. Guidewire 102 may be positioned, for example, by first placing crossing device 104 in the position shown in the previous figure, then advancing guidewire 102 through lumen 122 defined by shaft 120 of crossing device 104. Alternately, guidewire 102 may be disposed within lumen 122 while crossing device 104 is advanced beyond occlusion 36.


With guidewire 102 in the position shown in FIG. 5, guidewire 102 may be used to direct other devices between occlusion 36 and adventitia 24. For example, a catheter may be advanced over guidewire 102 until the distal end of the catheter extends between an occlusion and the adventia. After reaching this location, the catheter may be used to dilate the tissue surrounding the catheter. Examples of catheters that may be used to dilate tissue include balloon catheters and atherectomy catheters.



FIG. 6 is an additional view of artery 20 and guidewire 102 shown in the previous figure. In the embodiment of FIG. 6, an orienting device 106 has been advanced over guidewire 102. Orienting device 106 includes a shaft 120 comprising a wall 124 defining a lumen 122. A first aperture 126 and a second aperture 128 are also defined by wall 124. In the embodiment of FIG. 6, first aperture 126 and second aperture 128 are both in fluid communication with lumen 122.


In the embodiment of FIG. 6, orienting device 106 has been positioned so that first aperture 126 opens toward intima 26 of artery 20 and second aperture 128 opens toward adventitia 24. With reference to FIG. 6, it will be appreciated that first aperture extends in a first direction that is represented by a first arrow AA and second aperture extends in a second direction that is represented by a second arrow AB.


In FIG. 6, first arrow AA and second arrow AB are used to illustrate the fact that the second direction is general opposite the first direction. In the embodiment of FIG. 6, first arrow AA and second arrow AB are orient 180 degrees away from each other. In the embodiment of FIG. 6, first aperture 126 and second aperture 128 are longitudinally separated from one another. Orienting device 106 includes a radiopaque marker 130 that is located between first aperture 126 and second aperture 128.



FIG. 7 is an additional view of artery 20 and orienting device 106 shown in the previous figure. In the embodiment of FIG. 7, guidewire 102 has been withdrawn leaving orienting device 106 in the position shown in FIG. 7. With reference to FIG. 7, it will be appreciated that orienting device 106 extends beyond occlusion 36. In FIG. 7, occlusion 36 is shown blocking true lumen 30. Occlusion 36 divides true lumen 30 into a proximal segment 32 and a distal segment 34. When an orienting device in accordance with some embodiments disclosed herein is advanced between the adventitia and the intima of an artery, the orienting device may be used to direct a re-entry device toward true lumen 30. Fluid communication between proximal segment 32 and distal segment 34 may be achieved by re-entering the true lumen with the reentry device.



FIG. 8 is an additional view of artery 20 and orienting device 106 shown in the previous figure. In the embodiment of FIG. 8, a re-entry device 100 has been advanced into lumen 122 of orienting device 106. Some useful methods include the step of advancing the distal end of re-entry device 100 into true lumen 30.



FIG. 9 is an enlarged partial cross-sectional view showing a portion of re-entry device 100 and orienting device 106 shown in the previous figure. With reference to FIG. 9, it will be appreciated that re-entry device 100 includes a bend 130 near distal end 132 of re-entry device 100.



FIG. 10 is an additional partial cross-sectional view showing a portion of re-entry device 100 and orienting device 106. FIG. 10 is further enlarged and simplified relative to the items shown in the previous figure. In the embodiment of FIG. 10, a body 138 of re-entry device 100 is biased to assume a bent shape including a bend 130. Also in the embodiment of FIG. 10, shaft 120 of orienting device 106 is holding re-entry device 100 in a somewhat compressed state. When this is the case, re-entry device 100 can be inserted through first aperture 126 by positioning distal end 132 over first aperture 126 and allowing bend 130 to assume it's natural state (i.e., bent at a sharper angle). Re-entry device 100 can be inserted through aperture 126 until it comes into contact with intima 26.


In the embodiment of FIG. 10, distal end 132 of core 136 is axially aligned with first aperture 126, however, bend 130 is causing distal end 132 to point away from first aperture 126. When this is the case, distal end 132 may be positioned over first aperture 126 by rotating core 136.



FIG. 11 is an enlarged partial cross-sectional view showing a portion of re-entry device 100 and orienting device 106 shown in the previous figure. In the embodiment of FIG. 11, re-entry device 100 has been positioned so that a distal portion of re-entry device 100 has entered first aperture 126. Intima 26 is shown below first aperture 126 in FIG. 11.



FIG. 12 is an enlarged partial cross-sectional view showing a portion of re-entry device 100 and intima 26. With reference to FIG. 12, it will be appreciated that re-entry device 100 comprises a body 138 and a core 136. In the embodiment of FIG. 12, core 136 has been advanced so that a portion of core 136 extends beyond body 138. For purposes of illustration and exposition, the portion of core 136 extending beyond body 138 is referred to as a penetrator 140. Embodiments of re-entry device 100 are contemplated in which penetrator 140 is fixed in the position shown in FIG. 12.



FIG. 13 is an enlarged partial cross-sectional view showing a portion of re-entry device 100. In the embodiment of FIG. 13, re-entry device 100 has been advanced so that penetrator 140 is shown contacting intima 26 in FIG. 13.



FIG. 14 is an enlarged partial cross-sectional view showing a portion of re-entry device 100. In the embodiment of FIG. 14, penetrator 140 of re-entry device 100 has pierced intima 26.



FIG. 15 is an enlarged partial cross-sectional view showing a portion of re-entry device 100. In the embodiment of FIG. 15, re-entry device 100 has been advanced so that distal end 132 of re-entry device 100 is disposed in true lumen 30.



FIG. 16 is a partial cross-sectional view of re-entry device 100 shown in the previous figure. FIG. 16 has a different scale than the previous figure so that more of the surrounding context is visible in FIG. 16. In FIG. 16, distal end 132 of reentry device 100 can be seen residing in true lumen 30.



FIG. 17 is an additional view of artery 20 shown in the previous figure. In the embodiment of FIG. 17, orienting device 106 has been withdrawn leaving reentry device 100 in the position shown in FIG. 17. Devices such as balloon angioplasty catheters and atherectomy catheters may be advanced over re-entry device 100. In this way, these devices may be used in conjunction with re-entry device 100 to establish a blood flow path between proximal segment 32 of true lumen 30 and distal segment 34 of true lumen 30. This path allows blood to flow around occlusion 36.



FIG. 18 is a plan view of a re-entry device 100 in accordance with the present description. Crossing device 104 includes an elongate body 138 having a distal end 132 and a proximal end 134. In the embodiment of FIG. 18, a core 136 extends into a lumen 122 defined by body 138. In some useful embodiments, core 136 is free to advance and retract relative to body 138. When core 136 is moved relative to body 138, penetrator 140 can be caused to selectively assume the retracted position and/or the deployed position. In FIG. 18, penetrator 140 is shown in the deployed position.


In the embodiment of FIG. 18, an actuating fixture 142 is fixed to body 138 near proximal end 134. Also in FIG. 18, a pushing force is shown acting on a proximal portion of core 136. This pushing force is represented by an arrow PF in FIG. 18. Actuating fixture 142 may be used when creating relative motion between core 136 and body 138. Actuating fixture 142 may be held to hold body 138 relatively stationary and pushing/pulling forces may be applied to core 136 to move core 136 relative to body 138. In FIG. 18, body 138 of re-entry device 100 is shown being bent at an angle A. Accordingly, it can be said that re-entry device 100 includes a bend 130. In some useful embodiments of re-entry device 100, angle A is between about 120 degrees and about 150 degrees.



FIG. 19 is an additional plan view of re-entry device 100 shown in the previous figure. In the embodiment of FIG. 19, penetrator 140 is assuming a retracted position. A pulling force applied to core 136 while holding actuating fixture 142 relatively stationary may cause penetrator 140 to assume the retracted position.


With reference to the figures, it will be appreciated that when penetrator 140 is in the retracted position, the distal portion of re-entry device 100 has a less traumatic shape than when penetrator 140 is in the deployed position. Conversely, when penetrator 140 is in the deployed position, the distal portion of re-entry device 100 has a more traumatic shape than when penetrator 140 is in the retracted position.


The position of core 136 may be changed relative to body 138 by apply pushing and/or pulling forces on core 136 and body 138. In FIG. 19, a pulling force is represented with an arrow UF. A physician may utilize this mechanism to selectively alter the overall shape of a distal portion of re-entry device 100. Changes in the shape of the distal portion of re-entry device 100 may assist in re-entry through the intima.



FIG. 20 is a plan view of a re-entry device 100 illustrating selected dimensions of re-entry device 100. In the embodiment of FIG. 20, a penetrator 140 of core 136 extends beyond a distal end 132 of body 138 by a distance L1. In the embodiment of FIG. 20, penetrator 140 has a diameter D1 and body 138 has a diameter D2. With reference to FIG. 20, it will be appreciated that diameter D2 of body 138 is greater than diameter D1 of penetrator 140.


With reference to FIG. 20, it will be appreciated that body 138 of reentry device 100 includes a bend 130 near its distal end 132. Body 138 has a distal leg 144 disposed distally of bend 130 and a proximal leg 146 disposed proximally of bend 130. As shown in FIG. 20, distal leg 144 has a length of L2. With reference to FIG. 20, it will be appreciated that length L2 is greater than distance L1.


In some useful embodiments, diameter D1 of penetrator 140 is between about 0.0020 inches and about 0.0055 inches.


In some useful embodiments, diameter D2 of body 138 is between about 0.008 inches and about 0.015 inches.


In some useful embodiments, length L1 of penetrator 140 is between about 0.003 inches and about 0.012 inches.


In some useful embodiments, length L2 of distal leg 144 is between about 0.040 inches and about 0.080 inches.



FIG. 21 and FIG. 22 illustrate a method in which re-entry device 100 has been advanced while core 136 is in a retracted position. With reference to the figures, it will be appreciated that re-entry device 100 has not penetrated intima 26. Instead, re-entry device has been advanced between intima 26 and the exterior of orienting device 106.



FIG. 23A is a cross-sectional view of an orienting device 106. Orienting device 106 includes a shaft 120 comprising a wall 124 defining a lumen 122. Wall 124 defines a first aperture 126 and a second aperture 128 that are both in fluid communication with lumen 122. In the embodiment of FIG. 23A, first aperture 126 extends away from lumen 122 in a first direction that is represented by a first arrow AA in FIG. 23A. Second aperture 128 extends away from lumen 122 in a second direction that is represented by a second arrow AB in FIG. 23A. In FIG. 23A, first arrow AA and second arrow AB extend in generally opposite directions. Accordingly, the first direction is about 180 degrees from the second direction.


In the embodiment of FIG. 23A, first aperture 126 and second aperture 128 are longitudinally separated from one another. Orienting device 106 includes a first radiopaque marker 130A that is located between first aperture 126 and second aperture 128. A second radiopaque marker 130B of orienting device 106 is located distally of second aperture 128.


A re-entry device 100 is disposed in lumen 122 of orienting device 106. In the embodiment of FIG. 25A, first radiopaque marker 130A, second radiopaque marker 130B and re-entry device 100 comprise radiopaque materials. Because of the radiopaque nature of their materials of construction, first radiopaque marker 130A, second radiopaque marker 130B, and re-entry device 100 will all be visible on a fluoroscopic display during a fluoroscopic procedure.



FIG. 23B is a representation of a fluoroscopic display 148. First radiopaque marker 130A, second radiopaque marker 130B, and re-entry device 100 are visible in fluoroscopic display 148. In the embodiment of FIG. 23B, distal end 132 of re-entry device 100 is located slightly proximal of first radiopaque marker 130A. Accordingly, re-entry device 100 is seen extending across fluoroscopic display 148 and ending just short of first radiopaque marker 130A. When a physician views display 148 shown in FIG. 23B, the physician may infer that distal end 132 is proximate first aperture 126 of orienting device 106. After determining that distal end 132 of re-entry device 100 is in this location, the physician can rotate re-entry device 100 until distal end 132 enters into first aperture 126.



FIG. 24 is a plan view including orienting device 106 shown in the previous figure. In FIG. 24, a distal portion of re-entry device 100 can be seen extending through first aperture 126. First aperture 126 and second aperture 128 both fluidly communicate with lumen 122 of orienting device 106. Orienting device 106 includes a first radiopaque marker 130A that is located between first aperture 126 and second aperture 128. A second radiopaque marker 130B of orienting device 106 is located distally of second aperture 128.


Orienting device 106 comprises an elongate shaft 120, a first orienting element 150, and second orienting element (not visible in FIG. 24). First orienting element 150 comprises a first balloon 152 and second orienting element comprises a second balloon. When these balloons are inflated between the adventitia and the intima of a blood vessel, orienting device 106 will orient itself within the blood vessel so that either first aperture 126 or second aperture 128 will open toward a true lumen of the artery. The physician may select the aperture opening toward the true lumen using methods described herein. The physician may then use methods in accordance with this disclosure to insert distal end 132 of re-entry device 100 through the selected aperture.



FIG. 25A is a cross-sectional view of an orienting device 106. Orienting device 106 includes a shaft 120 comprising a wall 124 defining a lumen 122. In the embodiment of FIG. 25, a re-entry device 100 is disposed in lumen 122. Wall 124 defines a first aperture 126 and a second aperture 128 that are both in fluid communication with lumen 122.


In the embodiment of FIG. 25A, first aperture 126 and second aperture 128 are longitudinally separated from one another. Orienting device 106 includes a first radiopaque marker 130A that is located between first aperture 126 and second aperture 128. Orienting device 106 also comprises a second radiopaque marker 130B that is located distally of second aperture 128. With reference to FIG. 25A, it will be appreciated that first radiopaque marker 130A and second radiopaque maker 130B are both surrounded by wall 124 of shaft 120.


In the embodiment of FIG. 25A, first radiopaque marker 130A, second radiopaque marker 130B and re-entry device 100 comprise radiopaque materials. Because of the radiopaque nature of their materials of construction, first radiopaque marker 130A, second radiopaque marker 130B, and re-entry device 100 will all be visible on a fluoroscopic display during a fluoroscopic procedure.



FIG. 25B is a representation of a fluoroscopic display 148. First radiopaque marker 130A, second radiopaque marker 130B, and re-entry device 100 are visible in fluoroscopic display 148. In the embodiment of FIG. 25B, distal end 132 of re-entry device 100 is located slightly proximal of second radiopaque marker 130B. Accordingly, re-entry device 100 is seen extending across fluoroscopic display 148 and ending just short of second radiopaque marker 130B. When a physician views display 148 shown in FIG. 25B, the physician may infer that distal end 132 is proximate second aperture 126 of orienting device 106. After determining that distal end 132 of re-entry device 100 is in this location, the physician can rotate re-entry device 100 until distal end 132 enters into second aperture 126.



FIG. 26 is a plan view including orienting device 106 shown in the previous figure. Orienting device 106 comprises an elongate shaft 120, a first balloon 152, and a second balloon 154. In the embodiment of FIG. 26, first balloon 152 and second balloon 154 are both formed from extruded portions of an outer wall 124 of elongate shaft 120. Outer wall 124 defines a second aperture 128. In FIG. 26, a reentry device 100 is shown extending through second aperture 128.



FIG. 27 is a cross sectional view of orienting device 106 taken along line A-A shown in FIG. 26. With reference to FIG. 27, it will be appreciated that elongate shaft 120 defines a lumen 122A, a first planetary lumen 122B, and a second planetary lumen 122C. The planetary lumens are defined in part by an outer wall 124 of elongate shaft 120. Outer wall 124 defines a first aperture 126 and a second aperture 128.


In the embodiment of FIG. 27, a first balloon 152 is formed of an extruded portion of outer wall 124 of elongate shaft 120. First balloon 152 defines an interior that is in fluid communication with first planetary lumen 122B. In the embodiment of FIG. 27, first balloon 152 and elongate shaft 120 are monolithic. As shown in FIG. 27, first balloon 152 and outer wall 124 of elongate shaft 120 are seamlessly formed from a single piece of material. With reference to FIG. 27, it will be appreciated that second balloon 154 defines an interior that is in fluid communication with second planetary lumen 122C. In the embodiment of FIG. 27, second balloon 154 comprises an extruded portion of outer wall 124 of elongate shaft 120.


As shown in FIG. 27, second balloon 154 and elongate shaft 120 are seamlessly formed from a single piece of material. Second balloon 154 may be formed, for example, by extruding a portion of outer wall 124. In some useful embodiments, elongate shaft 120 comprises a thermoplastic material. When this is the case, elongate shaft 120 may be formed, for example, using an extrusion process. Also when this is the case, first balloon 152 and second balloon 154 may be formed by further extruding outer wall 124 of elongate shaft 120.



FIG. 28 is a cross-sectional view of an artery 20 having a wall 22. In FIG. 28, wall 22 of artery 20 is shown having three layers. The outermost layer of wall 22 is the adventitia 24 and the innermost layer of wall 22 is the intima 26. The tissues extending between intima 26 and adventitia 24 may be collectively referred to as the media 28. For purposes of illustration, intima 26, media 28 and adventitia 24 are each shown as a single homogenous layer in FIG. 28. In the human body, however, the intima and the media each comprise a number of sub-layers. The transition between the external most portion of the intima and the internal most portion of the media is sometimes referred to as the subintimal space. Intima 26 defines a true lumen 30 of artery 20.


In FIG. 28, orienting device 106 is shown disposed between adventitia 24 and intima 26 of artery 20. Orienting device 106 may be used to direct a re-entry device 100 toward true lumen 30 of artery 20 as shown in FIG. 28. The first aperture 126 and second aperture 128 are generally oriented at a right angle to a plane defined by first balloon 152 and second balloon 154. With this arrangement, each aperture is either directed toward true lumen 30 of artery 20 or 180 degrees away from true lumen 30 when first balloon 152 and second balloon 154 are inflated. In this way, orienting device 106 reduces the number of directions an aperture may be facing from 360 degrees of freedom to two degrees of freedom, 180 degrees apart.



FIG. 29 is a partial cross-sectional view of an exemplary crossing device 104. Crossing device 104 of FIG. 29 comprises a tip 108 that is fixed to a distal end of a shaft 120. In the exemplary embodiment of FIG. 29, shaft 120 comprises a coil 156, a sleeve 158, a tubular body 160, and a sheath 162.


Tip 108 is fixed to a distal portion of coil 156. Coil 156 comprises a plurality of filars that are wound in a generally helical shape. In some useful embodiments of crossing device 104, coil 156 comprises eight, nine or ten filars wound into the shape illustrated in FIG. 29. Crossing device 104 includes a sleeve 158 that is disposed about a portion of coil 156. Sleeve 158 may comprise, for example, PET shrink tubing, i.e. polyethylene terephthalate.


Sleeve 158 and coil 156 both extend into a lumen defined by a tubular body 160. Tubular body 160 may comprise, for example hypodermic tubing formed of Nitnol, i.e. nickel titanium. With reference to FIG. 29, it will be appreciated that a proximal portion of sleeve 158 is disposed between tubular body 160 and coil 156. In some embodiments of crossing device 104, a distal portion of tubular body 160 defines a helical cut. This helical cut may be formed, for example, using a laser cutting process. The helical cut may be shaped and dimensioned to provide an advantageous transition in lateral stiffness proximate the distal end of tubular body 160.


A proximal portion of coil 156 extends proximally beyond the distal end of tubular body 160. A hub is fixed to a proximal portion of coil 156 and a proximal portion of tubular body 160. The hub may comprise, for example, a luer fitting. A sheath 162 is disposed about a portion of tubular body 160 and a portion of sleeve 158. In some embodiments of crossing device 104, sheath 162 comprises HYTREL, a thermoplastic elastomer.


With reference to FIG. 29, it will be appreciated that tubular body 160, coil 156, sleeve 158, and sheath 162 each have a proximal end and a distal end. The proximal end of outer sleeve 158 is disposed between the proximal end of tubular body 160 and the proximal end of sleeve 158. The distal end of sleeve 158 is positioned proximate tip 108 that is fixed to the distal end of coil 156. The distal end of sheath 162 is located between the distal end of tubular body 160 and the distal end of sleeve 158. With reference to FIG. 29, it will be appreciated that sheath 162 overlays the distal end of tubular body 160.


With reference to FIG. 29, it will be appreciate that tip 108 has a generally rounded shape. The generally rounded shape of tip 108 may reduce the likelihood that crossing device 104 will penetrate the adventitia of an artery. Tip 108 may be formed from a suitable metallic material including but not limited to stainless steel, silver solder, and braze. Tip 108 may also be formed from suitable polymeric materials or adhesives including but not limited to polycarbonate, polyethylene and epoxy. In some embodiments of crossing device 104, the outer surface of tip 108 comprises a generally non-abrasive surface. For example, the outer surface of tip 108 may have a surface roughness of about 25 micrometers or less. A tip member having a relatively smooth outer surface may reduce the likelihood that the tip member will abrade the adventitia of an artery.



FIG. 30 is a plan view showing an assembly 164 including crossing device 104 shown in the previous figure. In the embodiment of FIG. 30, a drive assembly 166 is coupled to crossing device 104. In FIG. 30, drive assembly 166 is shown disposed about a proximal portion of shaft 120 of crossing device 104. Drive assembly 166 comprises a handle body 172 and an anchor 168.


As shown in FIG. 30, handle body 172 of drive assembly 166 is long enough to receive the thumb and forefingers of a right hand RH and a left hand LH. Anchor 168 of drive assembly 166 defines a hole 170. With reference to FIG. 30, it will be appreciated that a finger F of right hand RH is extending through hole 170 in anchor 168. Left hand LH and right hand RH may rotate handle body 172 of drive assembly 166. When this is the case, finger F extending through anchor 168 prevents anchor 168 from rotating while handle body 172 rotates.


In FIG. 30, a distal portion of handle body 172 is positioned between the thumb and forefinger of a left hand LH. A proximal portion of handle body 172 is disposed between the thumb and forefinger of a right hand RH. In some useful methods, crossing device 104 is rotated and axially advanced simultaneously. Rotation of crossing device 104 can be achieved by rolling handle body 172 between the thumb and forefinger one hand. Two hands can also be used as shown in FIG. 30. Rotating crossing device 104 assures that the coefficient of friction at the interface between the crossing device and the surrounding tissue will be a kinetic coefficient of friction and not a static coefficient of friction.



FIG. 31 is a cross-sectional view of assembly 164 shown in the previous figure. Assembly 164 includes a drive assembly 166 and a crossing device 104. With reference to FIG. 31, it will be appreciated that drive assembly 166 includes a central gear 202 that is fixed to shaft 120 of crossing device 104. Drive assembly 166 also includes a handle body 172. An internal gear 206 is fixed to handle body 172.


A plurality of planetary gears 204 are disposed between central gear 202. A ring 174 maintains the spacing between adjacent pairs planetary gears 204. Anchor 168 is fixed to ring 174. Anchor 168 defines a hole 170. Central gear 202, planetary gears 204, and internal gear 206 together form a gear train providing a mechanical advantage. Due to this mechanical advantage, a single rotation of handle body 172 results in many rotations of shaft 120 of crossing device 104.


In some useful methods in accordance with the present disclosure, crossing device 104 is rotated at a rotational speed of between about 2 revolutions per minute and about 200 revolutions per minute. In some particularly useful methods in accordance with the present disclosure, crossing device 104 is rotated at a rotational speed of between about 50 revolutions per minute and about 150 revolutions per minute. Crossing device 104 may be rotated by hand as depicted in the previous figure. It is also contemplated that a mechanical device (e.g., an electric motor) may be used to rotate crossing device 104.


Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.

Claims
  • 1. A method of crossing an occlusion in a true lumen of a blood vessel via a vascular wall, comprising: advancing an orienting device into a subintimal space of the vascular wall until a distal end of the orienting device is positioned distal of the occlusion, the orienting device including a shaft having a wall defining a lumen having a longitudinal axis, a first aperture through the wall in communication with the lumen, and a second aperture through the wall in communication with the lumen;wherein the first aperture opens in a first direction away from the longitudinal axis of the lumen of the orienting device, and the second aperture opens in a second direction away from the longitudinal axis of the lumen of the orienting device;advancing a re-entry device through the lumen of the orienting device to a position adjacent the first aperture; andadvancing a distal end of the re-entry device out the first aperture until the distal end of the re-entry device is positioned within the true lumen.
  • 2. The method of claim 1, further comprising: observing, via fluoroscopy, a position of the distal end of the re-entry device relative to the first aperture and the second aperture;confirming that the first aperture is facing the true lumen.
  • 3. The method of claim 2, wherein the first aperture is longitudinally offset from the second aperture.
  • 4. The method of claim 1, further comprising retracting a guidewire from the lumen of the orienting device prior to advancing the re-entry device through the lumen of the orienting device.
  • 5. The method of claim 1, wherein a body of the re-entry device is self-biased toward a bent configuration.
  • 6. The method of claim 5, wherein the body of the re-entry device includes a bend near the distal end of the re-entry device in the bent configuration.
  • 7. The method of claim 6, wherein the bend forms an angle between about 120 degrees and about 150 degrees.
  • 8. The method of claim 1, wherein the re-entry device further includes a penetrator disposed therein, the penetrator being configured to selectively shift between a retracted position and a deployed position.
  • 9. The method of claim 8, further comprising piercing an intima layer of the vascular wall with the penetrator before advancing the distal end of the re-entry device through the intima layer and into the true lumen.
  • 10. The method of claim 1, wherein the first direction and the second direction are about 180 degrees apart from each other around the longitudinal axis.
  • 11. The method of claim 1, wherein the orienting device includes a first radiopaque marker and a second radiopaque marker.
  • 12. The method of claim 11, wherein the second aperture is positioned distal of the first aperture.
  • 13. The method of claim 12, wherein the first radiopaque marker is disposed between the first aperture and the second aperture, and the second radiopaque marker is disposed distal to the second aperture.
  • 14. A method of crossing an occlusion in a true lumen of a blood vessel via a vascular wall, comprising: advancing an orienting device into a subintimal space of the vascular wall until a distal end of the orienting device is positioned distal of the occlusion, the orienting device including a shaft having a wall defining a first aperture opening in a first direction away from a longitudinal axis of the orienting device, the first aperture being longitudinally spaced apart from a second aperture opening in a second direction away from the longitudinal axis of the orienting device different from the first direction;advancing a distal end of a re-entry device having a pre-bent configuration through the orienting device and into contact with a layer of the vascular wall immediately adjacent the orienting device;observing the distal end of the re-entry device exit the orienting device through the first aperture or the second aperture to determine which aperture faces the true lumen; andadvancing the distal end of the re-entry device out the aperture that faces the true lumen until the distal end of the re-entry device is positioned within the true lumen.
  • 15. The method of claim 14, wherein the first direction and the second direction are about 180 degrees apart from each other around the longitudinal axis.
  • 16. The method of claim 14, wherein the orienting device includes a first radiopaque marker and a second radiopaque marker.
  • 17. The method of claim 16, wherein the second aperture is positioned distal of the first aperture.
  • 18. The method of claim 17, wherein the first radiopaque marker is disposed between the first aperture and the second aperture, and the second radiopaque marker is disposed distal to the second aperture.
  • 19. The method of claim 14, wherein the shaft includes a lumen in communication with the first aperture and the second aperture.
  • 20. The method of claim 19, wherein the lumen of the shaft is a guidewire lumen extending through a distal tip of the shaft along the longitudinal axis of the orienting device.
CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. application Ser. No. 13/470,854, filed May 14, 2012, which is a continuation of U.S. application Ser. No. 12/320,792, filed Feb. 4, 2009, now U.S. Pat. No. 8,202,246, which claims the benefit of U.S. Provisional Application No. 61/063,756, filed Feb. 5, 2008, the entire disclosures of which are incorporated herein by reference.

US Referenced Citations (307)
Number Name Date Kind
3749086 Kline et al. Jul 1973 A
4020829 Willson et al. May 1977 A
4080706 Heilman et al. Mar 1978 A
4233983 Rocco Nov 1980 A
4534363 Gold Aug 1985 A
4545390 Leary Oct 1985 A
4569347 Frisbie Feb 1986 A
4581017 Sahota Apr 1986 A
4619274 Morrison Oct 1986 A
4621636 Fogarty Nov 1986 A
4676249 Arenas et al. Jun 1987 A
4721117 Mar et al. Jan 1988 A
4747821 Kensey et al. May 1988 A
4748986 Morrison et al. Jun 1988 A
4762130 Fogarty et al. Aug 1988 A
4763647 Gambale Aug 1988 A
4774949 Fogarty Oct 1988 A
4819634 Shiber Apr 1989 A
4832047 Sepetka et al. May 1989 A
4841976 Packard et al. Jun 1989 A
4878495 Grayzel Nov 1989 A
4925445 Sakamoto et al. May 1990 A
4932419 de Toledo Jun 1990 A
4976689 Buchbinder et al. Dec 1990 A
4979939 Shiber Dec 1990 A
4984581 Stice Jan 1991 A
4990134 Auth Feb 1991 A
4991602 Amplatz et al. Feb 1991 A
5052404 Hodgson Oct 1991 A
5067489 Lind Nov 1991 A
5069226 Yamauchi et al. Dec 1991 A
5071406 Jang Dec 1991 A
5118907 Stout et al. Jun 1992 A
5120308 Hess Jun 1992 A
5127917 Niederhauser et al. Jul 1992 A
5129890 Bates et al. Jul 1992 A
5143122 Adkins Sep 1992 A
5147317 Shank et al. Sep 1992 A
5154705 Fleischhacker et al. Oct 1992 A
5171383 Sagae et al. Dec 1992 A
5174302 Palmer Dec 1992 A
5193546 Shaknovich Mar 1993 A
5201753 Lampropoulos et al. Apr 1993 A
5213111 Cook et al. May 1993 A
5228453 Sepetka Jul 1993 A
5230348 Ishibe et al. Jul 1993 A
5238004 Sahatjian et al. Aug 1993 A
5242759 Hall Sep 1993 A
5243996 Hall Sep 1993 A
5259393 Corso, Jr. et al. Nov 1993 A
5263493 Avitall Nov 1993 A
5275610 Eberbach Jan 1994 A
5282478 Fleischhaker, Jr. et al. Feb 1994 A
5303714 Abele et al. Apr 1994 A
5324263 Kraus et al. Jun 1994 A
5333620 Moutafis et al. Aug 1994 A
5354257 Roubin et al. Oct 1994 A
5354279 Hofling Oct 1994 A
5354623 Hall Oct 1994 A
5356418 Shturman Oct 1994 A
5363847 Viera Nov 1994 A
5365942 Shank Nov 1994 A
5368048 Stoy et al. Nov 1994 A
5368049 Raman et al. Nov 1994 A
5372144 Mortier et al. Dec 1994 A
5372587 Hammerslag et al. Dec 1994 A
5373856 Grenouillet Dec 1994 A
5379779 Rowland et al. Jan 1995 A
5383856 Bersin Jan 1995 A
5385152 Abele et al. Jan 1995 A
5409453 Lundquist et al. Apr 1995 A
5415178 Hsi et al. May 1995 A
5415637 Khosravi May 1995 A
5419777 Hofling May 1995 A
5421349 Rodriguez et al. Jun 1995 A
5443907 Slaikeu et al. Aug 1995 A
5458585 Salmon et al. Oct 1995 A
5464395 Faxon Nov 1995 A
5477864 Davidson Dec 1995 A
5488959 Ales Feb 1996 A
5498250 Prather Mar 1996 A
5501667 Verduin, Jr. Mar 1996 A
5505702 Arney Apr 1996 A
5531781 Alferness et al. Jul 1996 A
5534007 St. Germain et al. Jul 1996 A
5542434 Imran et al. Aug 1996 A
5555883 Avitall Sep 1996 A
5571122 Kelly et al. Nov 1996 A
5571169 Plaia et al. Nov 1996 A
5603720 Kieturakis Feb 1997 A
5622184 Ashby et al. Apr 1997 A
5636641 Fariabi Jun 1997 A
5637089 Abrams et al. Jun 1997 A
5640970 Arenas Jun 1997 A
5643298 Nordgren et al. Jul 1997 A
5645529 Fagan et al. Jul 1997 A
5655548 Nelson et al. Aug 1997 A
5664580 Erickson et al. Sep 1997 A
5683384 Gough Nov 1997 A
5695111 Nanis et al. Dec 1997 A
5695506 Pike et al. Dec 1997 A
5720300 Fagan et al. Feb 1998 A
5722424 Engelson Mar 1998 A
5728133 Kontos Mar 1998 A
5741270 Hansen et al. Apr 1998 A
5741429 Donadio, III et al. Apr 1998 A
5769796 Palermo et al. Jun 1998 A
5779721 Nash Jul 1998 A
5807241 Heimberger Sep 1998 A
5824071 Nelson et al. Oct 1998 A
5830222 Makower Nov 1998 A
5830224 Cohn et al. Nov 1998 A
5833631 Nguyen Nov 1998 A
5840046 Deem Nov 1998 A
5843050 Jones et al. Dec 1998 A
5871528 Camps et al. Feb 1999 A
5885227 Finlayson Mar 1999 A
5891055 Sauter Apr 1999 A
5910133 Gould Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5924998 Cornelius et al. Jul 1999 A
5935108 Katoh et al. Aug 1999 A
5944686 Patterson et al. Aug 1999 A
5947940 Beisel Sep 1999 A
5951494 Wang et al. Sep 1999 A
5954713 Newman et al. Sep 1999 A
5957900 Ouchi Sep 1999 A
5968064 Selmon et al. Oct 1999 A
5984878 Engelson Nov 1999 A
5989276 Houser et al. Nov 1999 A
5997517 Whitbourne Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6013055 Bampos et al. Jan 2000 A
6015405 Schwartz et al. Jan 2000 A
6022343 Johnson et al. Feb 2000 A
6027460 Shturman Feb 2000 A
6036707 Spaulding Mar 2000 A
6036717 Mers Kelly et al. Mar 2000 A
6042876 Deem Mar 2000 A
6059750 Fogarty et al. May 2000 A
6068638 Makower May 2000 A
6071281 Burnside et al. Jun 2000 A
6071292 Makower et al. Jun 2000 A
6081738 Hinohara et al. Jun 2000 A
6099542 Cohn et al. Aug 2000 A
6106485 McMahon Aug 2000 A
6117064 Apple et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6126649 VanTassel et al. Oct 2000 A
6139540 Rost et al. Oct 2000 A
6155264 Ressemann et al. Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6159225 Makower Dec 2000 A
6183432 Milo Feb 2001 B1
6186972 Nelson et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6203559 Davis et al. Mar 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217549 Selmon et al. Apr 2001 B1
6221049 Selmon et al. Apr 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235000 Milo et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6245030 DuBois et al. Jun 2001 B1
6246914 de la Rama et al. Jun 2001 B1
6254588 Jones et al. Jul 2001 B1
6258052 Milo Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6273899 Kramer Aug 2001 B1
6277133 Kanesaka Aug 2001 B1
6283940 Mulholland Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6283983 Makower et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6302870 Jacobsen Oct 2001 B1
6302875 Makower et al. Oct 2001 B1
6319230 Palasis Nov 2001 B1
6330884 Kim Dec 2001 B1
6337142 Harder et al. Jan 2002 B2
6358244 Newman et al. Mar 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6379319 Garibotto et al. Apr 2002 B1
6387119 Wolf et al. May 2002 B2
6398798 Selmon et al. Jun 2002 B2
6416523 Lafontaine Jul 2002 B1
6428552 Sparks Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6447539 Nelson et al. Sep 2002 B1
6475226 Belef et al. Nov 2002 B1
6485458 Takahashi Nov 2002 B1
6491660 Guo et al. Dec 2002 B2
6491707 Makower et al. Dec 2002 B2
6506178 Schubart et al. Jan 2003 B1
6508824 Flaherty et al. Jan 2003 B1
6508825 Selmon et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6514217 Selmon et al. Feb 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6561998 Roth et al. May 2003 B1
6565583 Deaton et al. May 2003 B1
6569143 Alchas et al. May 2003 B2
6569145 Shmulewitz et al. May 2003 B1
6569150 Teague et al. May 2003 B2
6579311 Makower Jun 2003 B1
6589164 Flaherty Jul 2003 B1
6599304 Selmon et al. Jul 2003 B1
6602241 Makower et al. Aug 2003 B2
6613081 Kim et al. Sep 2003 B2
6616675 Evard et al. Sep 2003 B1
6623448 Slater Sep 2003 B2
6638247 Selmon et al. Oct 2003 B1
6638293 Makower et al. Oct 2003 B1
6655386 Makower et al. Dec 2003 B1
6656195 Peters et al. Dec 2003 B2
6660024 Flaherty et al. Dec 2003 B1
6669709 Cohn et al. Dec 2003 B1
6685648 Flaherty et al. Feb 2004 B2
6685716 Flaherty et al. Feb 2004 B1
6694983 Wolf et al. Feb 2004 B2
6709444 Makower Mar 2004 B1
6719725 Milo et al. Apr 2004 B2
6726677 Flaherty et al. Apr 2004 B1
6746426 Flaherty et al. Jun 2004 B1
6746462 Selmon et al. Jun 2004 B1
6746464 Makower Jun 2004 B1
6786884 DeCant, Jr. et al. Sep 2004 B1
6800085 Selmon et al. Oct 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6837868 Fajnsztajn Jan 2005 B1
6860892 Tanaka et al. Mar 2005 B1
6863684 Kim et al. Mar 2005 B2
6866676 Kieturakis et al. Mar 2005 B2
6884225 Kato et al. Apr 2005 B2
6905505 Nash et al. Jun 2005 B2
6929009 Makower et al. Aug 2005 B2
6936056 Nash et al. Aug 2005 B2
6942641 Seddon Sep 2005 B2
6949125 Robertson Sep 2005 B2
6991617 Hektner et al. Jan 2006 B2
7004173 Sparks et al. Feb 2006 B2
7056325 Makower et al. Jun 2006 B1
7059330 Makower et al. Jun 2006 B1
7083588 Shmulewitz et al. Aug 2006 B1
7094230 Flaherty et al. Aug 2006 B2
7105031 Letort Sep 2006 B2
7134438 Makower et al. Nov 2006 B2
7137990 Hebert et al. Nov 2006 B2
7159592 Makower et al. Jan 2007 B1
7179270 Makower Feb 2007 B2
7191015 Lamson et al. Mar 2007 B2
7229421 Jen et al. Jun 2007 B2
7316655 Garibotto et al. Jan 2008 B2
7377910 Katoh May 2008 B2
7465286 Patterson et al. Dec 2008 B2
8465451 McRae Jun 2013 B2
20010000041 Selmon et al. Mar 2001 A1
20020002349 Flaherty et al. Jan 2002 A1
20020029052 Evans et al. Mar 2002 A1
20020052637 Houser et al. May 2002 A1
20020103459 Sparks et al. Aug 2002 A1
20030028200 Berg et al. Feb 2003 A1
20030040737 Merril et al. Feb 2003 A1
20030109809 Jen et al. Jun 2003 A1
20030120195 Milo et al. Jun 2003 A1
20030236542 Makower Dec 2003 A1
20040015193 Lamson et al. Jan 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040077971 Vetter Apr 2004 A1
20040102719 Keith et al. May 2004 A1
20040133225 Makower Jul 2004 A1
20040147902 McGuckin, Jr. Jul 2004 A1
20040158143 Flaherty et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040230156 Schreck et al. Nov 2004 A1
20040249277 Kato et al. Dec 2004 A1
20040249338 DeCant, Jr. et al. Dec 2004 A1
20050038467 Hebert et al. Feb 2005 A1
20050049574 Petrick et al. Mar 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177105 Shalev Aug 2005 A1
20050216044 Hong Sep 2005 A1
20050261663 Patterson et al. Nov 2005 A1
20060094930 Sparks et al. May 2006 A1
20060135984 Kramer et al. Jun 2006 A1
20060229646 Sparks Oct 2006 A1
20060265043 Mandrusov Nov 2006 A1
20060271078 Modesitt Nov 2006 A1
20070083220 Shamay Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070093779 Kugler Apr 2007 A1
20070093780 Kugler et al. Apr 2007 A1
20070093781 Kugler et al. Apr 2007 A1
20070093782 Kugler et al. Apr 2007 A1
20070093783 Kugler et al. Apr 2007 A1
20070265596 Jen Nov 2007 A1
20080103443 Kabrick et al. May 2008 A1
20080228171 Kugler Sep 2008 A1
20080243065 Rottenberg et al. Oct 2008 A1
20080243067 Rottenberg et al. Oct 2008 A1
20090088685 Kugler et al. Apr 2009 A1
20090124899 Jacobs et al. May 2009 A1
20090270890 Robinson et al. Oct 2009 A1
20100063534 Kugler et al. Mar 2010 A1
20100069945 Olson et al. Mar 2010 A1
20150005719 Fischell Jan 2015 A1
Foreign Referenced Citations (23)
Number Date Country
2209637 Jul 1996 CA
2251685 Sep 1998 CA
2251685 Nov 2008 CA
0820782 Jan 1998 EP
0820782 Oct 1998 EP
0868924 Oct 1998 EP
0868924 Dec 2004 EP
08257136 Oct 1996 JP
WO-9210142 Jun 1992 WO
9839041 Sep 1998 WO
0178822 Oct 2001 WO
0178822 Dec 2002 WO
2007033052 Mar 2007 WO
2008063621 May 2008 WO
2008063621 Aug 2008 WO
2007033052 Apr 2009 WO
2009054943 Apr 2009 WO
2009100129 Aug 2009 WO
2009100129 Oct 2009 WO
2009134346 Nov 2009 WO
2009134346 Jan 2010 WO
2010019241 Feb 2010 WO
2010044816 Apr 2010 WO
Non-Patent Literature Citations (4)
Entry
Bolia, Amman, Subintimal Angioplasty: Which Cases to Choose, How to Avoid Pitfalls and Technical Tips, Combined Session: Vascular Surgery and Interventional Radiology, pp. III 8.1-8.3.
Colombo, Antonio et al., Treating Chronic Total Occlusions Using Subintimal Tracking and Reentry: The STAR Technique, Catheterization and Cardiovascular Interventions, vol. 64:407-411 (2005).
International Preliminary Report on Patentability for PCT/US2009/033076 dated Aug. 10, 2010 (10 pages).
International Search Report PCT/US2009/033076 dated Aug. 17, 2009 (7 pages).
Related Publications (1)
Number Date Country
20180110525 A1 Apr 2018 US
Provisional Applications (1)
Number Date Country
61063756 Feb 2008 US
Continuations (2)
Number Date Country
Parent 13470854 May 2012 US
Child 15848892 US
Parent 12320792 Feb 2009 US
Child 13470854 US